Based on TCGA database and GTEx data, GEPIA2 revealed that WSCD2 mRNA expression in glioma tissues was lower than that in benign brain tissues (log2FC < 1, p < 0.01) (Fig. 1A). This evidence concerns the gene WSCD2 and glioma.